About CD BioSciences
CD BioSciences is dedicated to supporting partners in advancing cancer diagnostics, translational research, and clinical operations. By leveraging our state-of-the-art pathology platforms and high-precision testing technologies, we deliver end-to-end laboratory solutions across the entire drug development continuum—from Preclinical Studies and Nonclinical Testing to Central Laboratory Services and Clinical & Regulatory Support.
By integrating cutting-edge technologies including multiplex IHC/IF, NGS, liquid biopsy, MRD, flow cytometry, and AI-driven imaging analytics, our team delivers high-quality, reproducible, and fully compliant solutions to accelerate translational breakthroughs and clinical success.
